Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease

Keyphrases

• Axon 100%
• Myelin Damage 100%
• Demyelinating Diseases 100%
• Axonal Injury 100%
• Magnetic Resonance 100%
• Directional Diffusivity 100%
• Demyelination 66%
• Multiple Sclerosis 66%
• Prognostic Implications 33%
• Therapeutic Implications 33%
• Trauma 33%
• Mouse Model 33%
• Central Nervous System 33%
• Optic Nerve 33%
• Axon Injury 33%
• Retinal Ischemia 33%
• Diffusion Magnetic Resonance Imaging (dMRI) 33%
• Transverse Myelitis 33%
• Mutant Mice 33%
• Protein mutants 33%
• Structural Change 33%
• Wallerian Degeneration 33%
• Drug Therapy 33%
• Axial Diffusivity 33%
• Cervical Spinal Cord 33%
• Spinal Stenosis 33%
• Axonal Loss 33%
• Experimental Autoimmune Encephalomyelitis 33%
• White Matter Pathology 33%
• Axon Tract 33%
• Optic Neuritis 33%
• Radial Diffusivity 33%
• Acute Disseminated Encephalomyelitis 33%
• Brain Lesions 33%
• Myelin Basic Protein 33%
• Retinal Ganglion Cell Death 33%
• Permanent Disability 33%
• Dysmyelination 33%
• T2-hyperintense Lesion 33%
• Water Movement 33%
• Cuprizone-induced Demyelination 33%
• Myelin Abnormalities 33%

Neuroscience

• Myelin 100%
• Demyelinating Disease 100%
• Axon 100%
• Multiple Sclerosis 50%
• Retinal Ganglion Cell 25%
• Central Nervous System 25%
• Cell Death 25%
• Optic Nerve 25%
• Diffusion Tensor Magnetic Resonance Imaging 25%
• Mutant Protein 25%
• Wallerian Degeneration 25%
• Myelitis 25%
• Transverse Myelitis 25%
• Experimental Autoimmune Encephalomyelitis 25%
• Optic Neuritis 25%
• Acute Disseminated Encephalomyelitis 25%
• Brain Lesion 25%
• Demyelinating Disorder 25%
• Remyelinization 25%
• Myelin Basic Protein 25%
• Spinal Stenosis 25%
• Ischemia 25%
• Drug Therapy 25%